We previously reported that whereas systemic continuous infusion of parathyroid hormone (PTH) accelerated orthodontic tooth movement, systemic but intermittent injection of PTH did not increase the rate of tooth movement. Analysis of these data suggested that continuous administration of PTH could be applicable for orthodontic therapy. In the present study, we investigated whether local and chronic application of PTH(1-34) would accelerate orthodontic tooth movement. To increase the residence time of PTH in the injected area, we used methylcellulose (MC) gel (2% w/v) for a slow-release formulation of PTH. MC gel containing PTH (PTH-MC) continuously released biologically active PTH into the acceptor medium for more than 72 hrs in vitro. When male rats received a local injection of PTH-MC into the subpcriosteum in the mesio-palatal region of the maxillary first molar (M1) every other day, M1 movement, which was mesially drawn by an orthodontic coil spring attached to the maxillary incisors, was accelerated in a dose-dependent manner. PTH-MC injection at 1 μg/400 g body weight caused a 1.6-fold increase in the rate of tooth movement. The acceleration of tooth movement by PTH-MC injection was marked on days 6, 9, and 12. Local injection of PTH dissolved in saline without MC did not significantly accelerate tooth movement on day 6 or later. Histological examination revealed active osteoclastic bone resorption and a widened periodontal space on the compression side of the periodontal tissue in the PTH-MC-injected rats. These results suggest that local injection of PTH in a slow-release formulation is applicable to orthodontic therapy.
Brudvik P., Rygh P. ( 1993). The initial phase of orthodontic root resorption incident to local compression of the periodontal ligament. Eur J Orthod15:249-263.
2.
Chao CF, Shih C., Wang TM, Lo TH (1988). Effects of prostaglandin E, on alveolar bone resorption during orthodontic tooth movement. Acta Anat132:304-309.
3.
Collins MK, Sinclair PM (1988). The local use of vitamin D to increase the rate of orthodontic tooth movement. Am J Orthod Dentofac Orthop94:278-284.
4.
Dewhirst FE, Ago JM, Peros WJ, Stashenko P. (1987). Synergism between parathyroid hormone and interleukin 1 in stimulating bone resorption in organ culture. JBone Miner Res2:127-134.
5.
Filicori M., Flamigni C. (1988). GnRH agonists and antagonists. Current clinical status. Drugs35:63-82.
6.
Geisthoevel F., Hils K., Wieacker P., Breckwoldt M., Schultheiss H. (1989). Monthly administration of the LH-RH analogue decapeptyl for long-term treatment of ovarian dysfunctions and estrogen-dependent disorders . Int J Fertil34:262-270.
7.
Greenfield EM, Gornik SA, Horowitz MC, Donahue HJ, Shaw SM ( 1993). Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA. J Bone Miner Res8:1163-1171.
8.
Hock JM, Gera I. ( 1992). Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res7:65-72.
9.
Hock JM, Gera I., Fonseca J., Raisz LG (1988). Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats. Endocrinology122:2899-2904.
10.
Hock JM, Hummert JR, Boyce R., Fonseca J., Raisz LG (1989). Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivo. J Bone Miner Res4:449-458.
11.
Ibbotson KJ, Orcutt CM, D'Souza SM, Paddock CL, Arthur JA, Jankowsky ML, et al. (1992). Contrasting effects of parathyroid hormone and insulin-like growth factor I in an aged ovariectomized rat model of postmenopausal osteoporosis. J Bone Miner Res7:425-432.
12.
Jerome CP, Colwell A., Eastell R., Russell Rgg, Trechsel U. (1992). The effect of rat parathyroid hormone (1-34) infusion on urinary 3-hydroxypyridinium cross-link excretion in the rat. Bone Miner19:117-125.
13.
Kato Y., Nomura Y., Daikuhara Y., Nasu N., Tsuji M., Asada A., et al. (1980). Cartilage-derived factor (CDF) 1. Stimulation of proteoglycan synthesis in rat and rabbit costal chondrocytes in culture . Exp Cell Res130:73-81.
14.
Kato Y., Iwamoto M., Koike T. (1987). Fibroblast growth factor stimulates colony formation of differentiated chondrocytes in soft agar. J Cell Physiol133:491-498.
15.
Kenley R., Marden L., Turek T., Jin L., Ron E., Hollinger JO (1994). Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). J Biomed Mater Res28:1139-1147.
16.
Kitazawa R., Imai Y., Fukase M., Fujita T. (1991). Effects of continuous infusion of parathyroid hormone and parathyroid hormone-related peptide on rat bone in vivo: comparative study by histomorphometry. Bone Miner12:157-166.
17.
Koike T., Iwamoto M., Shimazu A., Nakashima K., Suzuki F., Kato Y. ( 1990). Potent mitogenic effects of parathyroid hormone (PTH) on embryonic chick and rabbit chondrocytes. Differential effects of age on growth, proteoglycan, and cyclic AMP responses of chondrocytes to PTH. J Clin Invest85 :626-631.
18.
Kumar S., Himmelstein KJ (1995). Modification of in situ gelling behavior of carbopol solutions by hydroxypropyl methylcellulose. J Pharm Sci84:344-348.
19.
Lee WC (1990). Experimental study of the effect of prostaglandin administration on tooth movement-with particular emphasis on the relationship to the method of PGE1 administration. Am J Orthod Dentofac Orthop98:231-241.
20.
Lee YH, Lee VH (1993). Formulation influence on ocular and systemic absorption of topically applied atenolol in the pigmented rabbit. J Ocul Pharmacol9:47-58.
21.
Liu CC, Kalu DN ( 1990). Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats. J Bone Miner Res5:973-982.
22.
Liu CC, Kalu DN, Salerno E., Echon R., Hollis BW, Ray M. (1991). Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone. J Bone Miner Res6:1071-1080.
23.
Lowik CW, van der Pluijm G., Bloys H., Hoekman K., Bijvoet OL, Aarden LA, et al. (1989). Parathyroid hormone (PTH) and PTHlike protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun162:1546-1552.
24.
Malluche HH, Sherman D., Meyer W., Ritz E., Norman AW, Massry SG (1982). Effects of long-term infusion of physiologic doses of 1-34 PTH on bone. Am J Physiol242:F197-F201.
25.
Okuda K., Wolff L., Oliver R., Osborn J., Stoltenberg J., Bereuter J., et al. (1992). Minocycline slow-release formulation effect on subgingival bacteria. J Periodontol63:73-79.
26.
Oostdijk W., Hummelink R., Odink RJ, Partsch CJ, Drop SL, Lorenzen F., et al. (1990). Treatment of children with central precocious puberty by a slow-release gonadotropin-releasing hormone agonist. Eur J Pediatr149:308-313.
27.
Paavola A., Yliruusi J., Kajimoto Y., Kalso E., Wahlstrom T., Rosenberg P. (1995). Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block. Pharm Res12:1997-2002.
28.
Patton JS, Trinchero P., Platz RM (1994). Bioavailability of pulmonary delivered peptides and proteins: a-interferon, calcitonins and parathyroid hormones. J Control Release26:79-85.
29.
Podbesek R., Edouard C., Meunier PJ, Parsons JA, Reeve J., Stevenson RW, et al. (1983). Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology112:1000-1006.
30.
Pollock JH, Blaha MJ, Lavish SA, Stevenson S., Greenfield EM (1996). in vivo demonstration that parathyroid hormone and parathyroid hormone-related protein stimulate expression by osteoblasts of interleukin-6 and leukemia inhibitory factor. J Bone Miner Res11:754-759.
31.
Schmidt IU, Dobnig H., Turner RT (1995). Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats. Endocrinology136:5127-5134.
32.
Soma S., Iwamoto M., Higuchi Y., Kurisu K. (1999). Effects of continuous infusion of PTH on experimental tooth movement in rats. J Bone Miner Res14:546-554.
33.
Takano-Yamamoto T., Rodan GA (1990). A model for investigating the local action of bone-acting agents in vivo: effects of hPTH(1-34) on the secondary spongiosa in the rat. Calcif Tissue Int47:158-163.
34.
Takano-Yamamoto T., Kawakami M., Kobayashi Y., Yamashiro T., Sakuda M. (1992a). The effect of local application of 1,25-dihydroxycholecalciferol on osteoclast numbers in orthodontically treated rats. J Dent Res71:53-59.
35.
Takano-Yamamoto T., Kawakami M., Yamashiro T. (1992b). Effect of age on the rate of tooth movement in combination with local use of 1,25(OH)2D3 and mechanical force in the rat . J Dent Res71:1487-1492.
36.
Uematsu S., Mogi M., Deguchi T. (1996). Interleukin (IL)-l beta, IL-6, tumor necrosis factor-alpha, epidermal growth factor, and beta 2-microglobulin levels are elevated in gingival crevicular fluid during human orthodontic tooth movement . J Dent Res75:562-567.
37.
Waldo CM, Rothblatt JM (1954). Histologic response to tooth movement in the laboratory rat. J Dent Res33:481-486.
38.
Yamasaki K., Miura F., Suda T. ( 1980). Prostaglandin as a mediator of bone resorption induced by experimental tooth movement in rats. J Dent Res59:1635-1642.
39.
Yamasaki K., Shibata Y., Imai S., Tani Y., Shibasaki Y., Fukuhara T. (1984). Clinical application of prostaglandin E1 (PGE1) upon orthodontic tooth movement. Am J Orthod85:508-518.
